Skip Navigation LinksHome > February 1993 - Volume 78 - Issue 2 > Sufentanil Disposition: Is It Affected by Erythromycin Admin...
Anesthesiology:
CLINICAL INVESTIGATIONS: PDF Only

Sufentanil Disposition: Is It Affected by Erythromycin Administration?.

Bartkowski, Richard R. M.D., Ph.D.; Goldberg, Michael E. M.D.; Huffnagle, Suzanne D.O.; Epstein, Richard H. M.D

Collapse Box

Abstract

Background: Because oral erythromycin administration has been associated with reduced elimination of alfentanil, suspicion has been raised about related opioids with similar metabolic pathways. A controlled crossover study of sufentanil pharmacokinetics was undertaken to resolve this issue.
Methods: Six subjects had measurements of plasma concentrations for 9 h after intravenous administration of sufentanil (3 [mu]gAg). Each subject was studied following no erythromycin (control) and after 1- and 7-day courses of erythromycin base.
Results: Plasma concentrations during the 9 h of measurement were similar before and after erythromycin. Terminal half-life and clearance and distribution volume did not change significantly among treatment groups. Values measured after 7 days of erythromycin were similar to controls.
Conclusions: Prior administration of erythromycin docs not alter pharmacokinetics of sufentanil in the 9 h following sufentanil administration. Thus, there are no apparent clinical consequences of prior or concomitant erythromycin administration in patients receiving sufentanil for procedures of 9 h or less.
(C) 1993 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.